Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas
- Status
- COMPLETED
- Phase
- PHASE2
Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
- Status
- UNKNOWN
- Phase
- PHASE3
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
- Status
- COMPLETED
- Phase
- PHASE2
Combination of Irinotecan and Temozolomide in Children With Brain Tumors.
- Status
- COMPLETED
- Phase
- PHASE2
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract
- Status
- COMPLETED
- Phase
- PHASE2
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2